Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Monica Higuera Urbano

Monica Higuera Urbano

Institutions of which they are part

Research technician
Liver Diseases
Vall Hebron Institut de Recerca
Monica Higuera Urbano

Monica Higuera Urbano

Monica Higuera Urbano

Institutions of which they are part

Research technician
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Malalties hepàtiques

IP: Joan Genescà Ferrer
Collaborators: Beatriz Minguez Rosique, Sergi Colomer Castell, Elena Vargas Accarino, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Maria Buti Ferret, Montserrat Gomez Perez, Judit Romero Vico, Josep Quer Sivila, Adriana Palom Agusti, Juan Manuel Pericàs Pulido, Maria Nieves Martell Pérez-Alcalde, Damir Garcia Cehic, Daniel Martinez Vazquez, Laura Puente Ramo, Isabel Campos Varela, María Bermúdez Ramos, Juan Ignacio Esteban Mur, Ester Palacio Gutierrez, Susana Anton Calvo, Monica Higuera Urbano, Meritxell Ventura Cots, Ares Aurora Villagrasa Vilella, Emma Bigas Alsina, Carolina Campos Martinez, Macarena Simon-Talero Horga, David Tabernero Caellas, Mònica Pons Delgado, Marcella Salzano
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00462
Duration: 01/01/2022 - 30/06/2025

Aislamiento y caracterización molecular de Células Tumorales Circulantes (CTCs): potenciales biomarcadores en Carcinoma Hepatocelular

IP: Beatriz Minguez Rosique
Collaborators: Itxarone Izaskun Bilbao Aguirre, Elena Vargas Accarino, Maria Teresa Salcedo Allende, Monica Higuera Urbano
Funding agency: Instituto de Salud Carlos III
Funding: 183920
Reference: PI21/00714
Duration: 01/01/2022 - 31/12/2025

Utilidad de la biopsia líquida en el diagnóstico molecular, seguimiento y manejo terapéutico del carcinoma hepatocelular.

IP: Beatriz Minguez Rosique
Collaborators: Itxarone Izaskun Bilbao Aguirre, Maria Teresa Salcedo Allende, Monica Higuera Urbano
Funding agency: Instituto de Salud Carlos III
Funding: 129470
Reference: PI18/00961
Duration: 01/01/2019 - 31/12/2022

Lipotoxicity, Hepatic Steatosis and Hepatocarcinoma: role of the Armc10/Armcx family of mitochondrial proteins

IP: Beatriz Minguez Rosique
Collaborators: Monica Higuera Urbano
Funding agency: Fundació La Marató de TV3
Funding: 98437.5
Reference: 20133732
Duration: 14/03/2014 - 13/03/2017

Related news

Dr. Raul Herance

We develop a method to diagnose fatty liver in a quantitative and non-invasive way

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Pacient d'un assaig clínic a la consulta

VHIR exceeds 700 active clinical trials to achieve new therapies for patients

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Grup de Malalties Hepàtiques del VHIR

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

See more

Related professionals

Isabel Claveria Guiu

Isabel Claveria Guiu

Infectious Diseases
Read more
Anna Belen Canovas Segura

Anna Belen Canovas Segura

Research technician
Peripheral Nervous System
Read more
Felipe Hernando Bartolome

Felipe Hernando Bartolome

Molecular Medical Imaging
Read more
Julieta Torchia

Julieta Torchia

Predoctoral researcher
Kidney Physiopathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.